Monalisa Chatterjee
Monalisa Chatterjee
Carnegie Institution For Science
No hay ninguna dirección de correo electrónico verificada.
TítuloCitado porAño
26.6 Kurz gesagt
WN Adger, DJ Arent, J Barnett, R Betts, TE Bilir, J Birkmann, J Carmin, ...
Klimawandel in Deutschland, 275, 0
3.1 Shifting Vulnerabilities: A Study in Flood Affected Slums of Mumbai
M Chatterjee
Resilience and Social Vulnerability, 100, 2008
32008
3344 Relationship between pembrolizumab exposure and efficacy/safety in 1016 patients (pts) with advanced or metastatic melanoma
SP Kang, M Chatterjee, M Ahamadi, D De Alwis, R De Greef, ...
European Journal of Cancer 51, S682, 2015
22015
9 Case study: floods in Mumbai
M Chatterjee
Routledge Handbook of Climate Change and Society, 192-206, 2010
12010
Abstract CT112: Exposure-response analysis of pembrolizumab in patients with advanced melanoma and non-small cell lung cancer enrolled in KEYNOTE-001,-002, and-006
MS Chatterjee, DC Turner, M Ahamadi, R de Greef, T Freshwater, ...
Cancer Research 76 (14 Supplement), CT112-CT112, 2016
22016
Adaptation planning and implementation
N Mimura, RS Pulwarty, I Elshinnawy, MH Redsteer, HQ Huang, JN Nkem, ...
Climate Change 2014 Impacts, Adaptation and Vulnerability: Part A: Global …, 2015
1692015
Advancing Climate Change Adaptation: Borrowing from the Natural Hazard Research (NHR) Tradition in Geography
M Chatterjee
Journal of Extreme Events 3 (02), 1602001, 2016
2016
Agents Cirad, auteurs de cette publication
I Niang, OC Ruppel, P Dube, NA Leary, MAK Abdrabo, A Essel, ...
APPLICATION OF TRANSLATIONAL PHARMACOKINETIC/PHARMACODYNAMIC (TPK/PD) PRINCIPLES TO DEFINE STANDARD OF CARE TO GUIDE DISCOVERY AND EARLY DEVELOPMENT.: PI-069
W Comisar, J Talaty, M Chatterjee, R Ogert, L Caro, R Kong, R Rippley
Clinical Pharmacology & Therapeutics 95 (1), 2014
2014
Assessment of pembrolizumab (MK-3475) dosing strategy based on population pharmacokinetics and exposure-response models
T Freshwater, J Stone, R de Greef, A Kondic, DP De Alwis, K Mayawala, ...
Journal of Pharmacokinetics and Pharmacodynamics 42, S15-S15, 2015
122015
Cambio climático 2014 Impactos, adaptación y vulnerabilidad
CB Field, V Barros, D Dokken, K Mach, M Mastrandrea, T Bilir
Quinto Informe de Evaluación (GTII IE5) del IPCC, 2014
142014
CAMBIO CLIMÁTICO 2014 Impactos, adaptación y vulnerabilidad
ES Kissel, MD Mastrandrea, PR Mastrandrea, LL White, RC Genova, ...
2014
Cambridge University Press: Cambridge
CB Field, V Barros, TF Stocker, D Qin, DJ Dokken, KL Ebi, ...
UK, 2012
1872012
Cambridge University Press: New York
VR Barros, CB Field, DJ Dokken, MD Mastrandrea, KJ Mach, TE Bilir, ...
NY, USA, 2014
82014
Central and south america
GO Magrin, JA Marengo, JP Boulanger, MS Buckeridge, E Castellanos, ...
3122017
Climate change 2001: impacts, adaptation, and vulnerability: contribution of Working Group II to the third assessment report of the Intergovernmental Panel on Climate Change
JJ McCarthy, OF Canziani, NA Leary, DJ Dokken, KS White
Cambridge University Press, 2001
6214*2001
Climate Change 2014: Impacts, Adaptation, and Vulnerability: Summaries, Frequently Asked Questions, and Cross-Chapter Boxes: A Working Group II Contribution to the Fifth …
CB Field, VR Barros, DJ Dokken, KJ Mach, MD Mastrandrea, TE Bilir, ...
Intergovernmental Panel on Climate Change, 2014
122014
Climate change 2014: mitigation of climate change
O Edenhofer
Cambridge University Press, 2015
8212015
D-08 Anna Georgieva Kondic Model-based analysis of the relationship between pembrolizumab exposure and efficacy in patients with melanoma and NSCLC: across indication comparison
M Chatterjee, DC Turner, M Ahamadi, D de Alwis, J Elassaiss-Schaap, ...
Differential sensitivity of gastric and small intestinal muscles to inducible knockdown of anoctamin 1 and the effects on gastrointestinal motility
SJ Hwang, DM Pardo, H Zheng, Y Bayguinov, PJ Blair, R Fortune‐Grant, ...
The Journal of physiology 597 (9), 2337-2360, 2019
22019
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20